The Roseoloviruses Downregulate the Protein Tyrosine Phosphatase PTPRC (CD45).
Cell Line
Down-Regulation
Gene Expression Regulation, Enzymologic
Gene Expression Regulation, Viral
HEK293 Cells
Herpesvirus 6, Human
/ genetics
Herpesvirus 7, Human
/ genetics
Humans
Leukocyte Common Antigens
/ genetics
Protein Stability
Receptors, Antigen, T-Cell
/ metabolism
T-Lymphocytes
/ immunology
CD45
HHV-6A
HHV-7
PTPRC
T cell activation
Zap70
herpesviruses
immune evasion
Journal
Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724
Informations de publication
Date de publication:
24 06 2021
24 06 2021
Historique:
pubmed:
7
5
2021
medline:
25
8
2021
entrez:
6
5
2021
Statut:
ppublish
Résumé
Like all herpesviruses, the roseoloviruses (HHV6A, -6B, and -7) establish lifelong infection within their host, requiring these viruses to evade host antiviral responses. One common host-evasion strategy is the downregulation of host-encoded, surface-expressed glycoproteins. Roseoloviruses have been shown to evade the host immune response by downregulating NK-activating ligands, class I MHC, and the TCR/CD3 complex. To more globally identify glycoproteins that are differentially expressed on the surface of HHV6A-infected cells, we performed cell surface capture of N-linked glycoproteins present on the surface of T cells infected with HHV6A, and compared these to proteins present on the surface of uninfected T cells. We found that the protein tyrosine phosphatase CD45 is downregulated in T cells infected with HHV6A. We also demonstrated that CD45 is similarly downregulated in cells infected with HHV7. CD45 is essential for signaling through the T cell receptor and, as such, is necessary for developing a fully functional immune response. Interestingly, the closely related betaherpesviruses human cytomegalovirus (HCMV) and murine cytomegalovirus (MCMV) have also separately evolved unique mechanisms to target CD45. While HCMV and MCMV target CD45 signaling and trafficking, HHV6A acts to downregulate CD45 transcripts.
Identifiants
pubmed: 33952641
pii: JVI.01628-20
doi: 10.1128/JVI.01628-20
pmc: PMC8223955
doi:
Substances chimiques
Receptors, Antigen, T-Cell
0
Leukocyte Common Antigens
EC 3.1.3.48
PTPRC protein, human
EC 3.1.3.48
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0162820Subventions
Organisme : NIGMS NIH HHS
ID : T32 GM080202
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI123745
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL134010
Pays : United States
Références
Cell. 2014 Jun 5;157(6):1460-1472
pubmed: 24906157
Annu Rev Immunol. 2000;18:861-926
pubmed: 10837078
Science. 1994 Feb 25;263(5150):1136-9
pubmed: 7509083
Eur J Immunol. 1982 May;12(5):387-92
pubmed: 6980126
Stem Cell Reports. 2016 Sep 13;7(3):543-556
pubmed: 27569060
PLoS Pathog. 2014 May 01;10(5):e1004058
pubmed: 24787765
J Biol Chem. 1992 Apr 5;267(10):7139-47
pubmed: 1532394
J Immunol. 1996 Oct 15;157(8):3375-80
pubmed: 8871634
J Virol. 2018 Aug 16;92(17):
pubmed: 29950412
Cell Rep. 2017 May 16;19(7):1479-1493
pubmed: 28514666
J Clin Invest. 2001 Jun;107(12):1599-606
pubmed: 11413168
Lancet. 1988 May 14;1(8594):1065-7
pubmed: 2896909
Eur J Immunol. 1992 May;22(5):1173-8
pubmed: 1533589
J Immunol. 2001 Jan 15;166(2):1308-13
pubmed: 11145714
Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2037-41
pubmed: 1672451
PLoS Pathog. 2019 Mar 14;15(3):e1007650
pubmed: 30870532
J Immunol. 2008 Apr 1;180(7):4836-47
pubmed: 18354207
Cell Rep. 2015 Feb 17;10(6):968-982
pubmed: 25683719
Nat Med. 2000 Mar;6(3):343-5
pubmed: 10700239
Int J Biochem Cell Biol. 2001 Nov;33(11):1041-6
pubmed: 11551820
Proteomics. 2017 Mar;17(5):
pubmed: 27966262
Curr Protoc Cell Biol. 2015 Sep 01;68:4.30.1-4.30.10
pubmed: 26331985
J Biol Chem. 1993 Sep 15;268(26):19797-801
pubmed: 8366117
Cell. 1992 Nov 13;71(4):649-62
pubmed: 1423621
PLoS Pathog. 2017 Jun 19;13(6):e1006454
pubmed: 28628650
J Leukoc Biol. 2018 Oct;104(4):821-832
pubmed: 30040158
J Virol. 1995 Aug;69(8):4830-41
pubmed: 7609050
Nature. 1990 Jul 5;346(6279):66-8
pubmed: 2164155
Front Immunol. 2019 Jul 25;10:1704
pubmed: 31402911
PLoS Pathog. 2016 Dec 7;12(12):e1006057
pubmed: 27926943
PLoS Pathog. 2011 Nov;7(11):e1002362
pubmed: 22102813
J Biol Chem. 1999 Mar 5;274(10):6285-94
pubmed: 10037717
PLoS Pathog. 2013 Mar;9(3):e1003226
pubmed: 23555244
Clin Exp Immunol. 1997 Sep;109(3):421-5
pubmed: 9328116
J Exp Med. 1987 Nov 1;166(5):1548-66
pubmed: 2824653
N Engl J Med. 2005 Feb 24;352(8):768-76
pubmed: 15728809
Immunology. 2006 Feb;117(2):145-55
pubmed: 16423050
J Immunol. 2003 Jul 15;171(2):902-8
pubmed: 12847260
Cell. 1989 Sep 22;58(6):1055-65
pubmed: 2550143
Stem Cell Reports. 2014 Jun 06;3(1):185-203
pubmed: 25068131
Proc Natl Acad Sci U S A. 1989 Aug;86(16):6302-6
pubmed: 2548204
Virology. 2010 Nov 25;407(2):360-7
pubmed: 20863544
Mol Cell. 2017 Aug 3;67(3):498-511.e6
pubmed: 28735895
PLoS One. 2013 Aug 12;8(8):e72050
pubmed: 23951282
J Virol. 2002 Aug;76(16):8179-88
pubmed: 12134023
Nat Biotechnol. 2009 Apr;27(4):378-86
pubmed: 19349973
PLoS Pathog. 2011 Dec;7(12):e1002432
pubmed: 22174689
New Microbiol. 1999 Oct;22(4):293-300
pubmed: 10555198
J Proteome Res. 2019 Apr 5;18(4):1644-1656
pubmed: 30795648
J Virol. 2008 Jan;82(2):602-8
pubmed: 17977973
mBio. 2017 Oct 10;8(5):
pubmed: 29018115
Cell Host Microbe. 2015 Oct 14;18(4):409-23
pubmed: 26439863
J Virol. 2001 Jul;75(13):5958-64
pubmed: 11390597
Nature. 1995 Jun 1;375(6530):415-8
pubmed: 7760936
J Virol. 2003 Apr;77(8):4950-9
pubmed: 12663800
J Immunol. 1988 Oct 15;141(8):2781-7
pubmed: 2971730
J Virol. 2003 Jul;77(13):7563-74
pubmed: 12805456
Nature. 1995 Sep 7;377(6544):32-8
pubmed: 7659156
EMBO J. 1987 May;6(5):1251-7
pubmed: 2956090
J Immunol. 2011 Dec 1;187(11):5745-55
pubmed: 22021615
J Virol Methods. 1998 Aug;73(2):123-40
pubmed: 9766884
J Immunol. 1986 Oct 1;137(7):2299-306
pubmed: 3760563
J Virol. 2010 Feb;84(3):1265-75
pubmed: 19923186
Cold Spring Harb Perspect Biol. 2010 May;2(5):a002279
pubmed: 20452964
Sci STKE. 2003 Apr 08;2003(177):PL8
pubmed: 12684528
PLoS Pathog. 2006 Oct;2(10):e107
pubmed: 17238276
Cell. 1994 May 20;77(4):525-35
pubmed: 8187174
Nat Immunol. 2001 Nov;2(11):1077-84
pubmed: 11668340
Viruses. 2018 Jul 29;10(8):
pubmed: 30060604
Eur J Immunol. 1999 Oct;29(10):3245-53
pubmed: 10540336
J Virol. 2014 Sep;88(18):10990-4
pubmed: 25008927
J Virol. 1997 Apr;71(4):2970-9
pubmed: 9060656
Bioinformatics. 2010 Apr 1;26(7):966-8
pubmed: 20147306
Blood. 2006 Sep 15;108(6):1932-40
pubmed: 16601245
Proc Natl Acad Sci U S A. 2013 Dec 10;110(50):E4884-93
pubmed: 24218549
J Virol. 1996 Sep;70(9):5975-89
pubmed: 8709220
Annu Rev Immunol. 2003;21:107-37
pubmed: 12414720
J Virol. 1999 Oct;73(10):8053-63
pubmed: 10482554
J Virol. 2001 Dec;75(24):12347-58
pubmed: 11711625
Immunol Lett. 2018 Apr;196:22-32
pubmed: 29366662
Blood. 2005 Aug 15;106(4):1305-13
pubmed: 15845898
J Virol. 2014 Mar;88(6):3298-308
pubmed: 24390327
Virology. 2007 Aug 15;365(1):125-35
pubmed: 17467766
Oncogene. 1990 Jun;5(6):809-13
pubmed: 2141684
Science. 2007 Jul 20;317(5836):376-81
pubmed: 17641203
Bioinformatics. 2014 Mar 15;30(6):884-6
pubmed: 24162465
Methods Mol Biol. 2018;1722:57-78
pubmed: 29264798
Cell. 1996 Mar 8;84(5):769-79
pubmed: 8625414